Condition: Acute Kidney Injury · Sponsor: SeaStar Medical
This randomized, controlled, pivotal study is intended to determine whether up to ten sequential 24-hour treatments with the Selective Cytopheretic Device (SCD) will improve survival in patients with Acute Kidney Injury (AKI) requiring continuous kidney replacement therapy (CKRT) when compared to CKRT alone (standard of care). This study is further intended to determine whether SCD therapy will reduce the duration of maintenance dialysis secondary to AKI. This study will enroll approximately 339 subjects across 30 US sites. Participants will be patients in an intensive care unit (ICU) setting with a diagnosis of AKI requiring CKRT.
This description comes directly from the study's public registry record.
Mohamed Zidan, MD · 844-427-8100 · mzidan@seastarmed.com
Kevin K Chung, MD · 844-427-8100 · kchung@seastarmed.com
Always discuss trial participation with your own doctor first.
| University of Alabama Birmingham Hospital | Birmingham, Alabama, United States | Recruiting |
| Mayo Clinic in Arizona | Phoenix, Arizona, United States | Not Yet Recruiting |
| Ronald Reagan UCLA Medical Center | Los Angeles, California, United States | Recruiting |
| Stanford University | Palo Alto, California, United States | Recruiting |
| University of California San Francisco | San Francisco, California, United States | Not Yet Recruiting |
| University of Colorado Hospital Anschutz Medical Campus | Aurora, Colorado, United States | Withdrawn |
| Mayo Clinic in Florida | Jacksonville, Florida, United States | Not Yet Recruiting |
| AdventHealth Orlando | Orlando, Florida, United States | Not Yet Recruiting |
| Orlando Regional Medical Center | Orlando, Florida, United States | Withdrawn |
| Emory Healthcare | Atlanta, Georgia, United States | Not Yet Recruiting |
| JMS Burn Center | Augusta, Georgia, United States | Withdrawn |
| Northeast Georgia Health System | Gainesville, Georgia, United States | Not Yet Recruiting |
+ 26 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05758077